HYPERKERATOSIS FOLLICULARIS ET PARAFOLLICULARIS

HYPERKERATOSIS FOLLICULARIS ET PARAFOLLICULARIS was reported 17 times

HYPERKERATOSIS FOLLICULARIS ET PARAFOLLICULARIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anthelmintic [EPC] 1 0.0003
1 Human Immunoglobulin G [EPC] 5 0.0002
2 Dietary Cholesterol Absorption Inhibitor [EPC] 5 0.0001
3 beta-Adrenergic Blocker [EPC] 5 0.0000
4 Insulin Analog [EPC] 6 0.0000
5 Proton Pump Inhibitor [EPC] 5 0.0000
6 Aldosterone Antagonist [EPC] 1 0.0000
7 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
8 Mood Stabilizer [EPC] 1 0.0000
9 Alkylating Drug [EPC] 1 0.0000
10 Retinoid [EPC] 1 0.0000
11 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
12 Atypical Antipsychotic [EPC] 1 0.0000
13 Loop Diuretic [EPC] 1 0.0000
14 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
15 Thalidomide Analog [EPC] 1 0.0000
16 Kinase Inhibitor [EPC] 1 0.0000
17 Tumor Necrosis Factor Blocker [EPC] 1 0.0000